Company / Revenue
Bio-Techne Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.2B
FY2025
5-year range
$714.0M / $1.2B
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#97 of 156
Health Care
What the data says
At $1.2B, Bio-Techne's revenue ranks #97 of 156 in the Health Care sector. Revenue has increased for 4 consecutive years, from $714M in FY2021 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +10.5%.
Improved from $931M to $1.2B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +18.2%
- 5-Year CAGR
- +10.5%
- 10-Year CAGR
- -
Sector benchmark
#97 of 156 in Health CareTop 62% of 156This company $1.2B Sector average $19.0B
▼
-93.6% below sector average
Key checks
Key Insights
- Bio-Techne's revenue has grown for 4 consecutive years.
- 5-year CAGR of +10.5%, indicating consistent growth.
- In FY2025, revenue increased 5.2% year-over-year.
- Ranks #97 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +5.2% |
| FY2024 | $1.2B | +24.5% |
| FY2023 | $931.0M | +26.0% |
| FY2022 | $738.7M | +3.5% |
| FY2021 | $714.0M | -3.3% |
| FY2020 | $738.7M | +3.5% |
| FY2019 | $714.0M | +11.0% |
| FY2018 | $643.0M | +14.2% |
| FY2017 | $563.0M | +12.8% |
| FY2016 | $499.0M | +10.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026